Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $7.1150 (-9.02%) ($7.1150 - $7.1150) on Mon. Sep. 25, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.67% (three month average) | RSI | 20 | Latest Price | $7.1150(-9.02%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -2.3% a day on average for past five trading days. | Weekly Trend | EDIT declines -7.1% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) ARKG(73%) XBI(71%) IBB(61%) ARKK(59%) IBUY(59%) | Factors Impacting EDIT price | EDIT will decline at least -1.335% in a week (0% probabilities). TBT(-25%) UUP(-15%) VXX(-12%) VIXM(-10%) USO(4%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.335% (StdDev 2.67%) | Hourly BBV | -1.9 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-4.31(-160.58%) | Resistance Level | $8.53 | 5 Day Moving Average | $7.78(-8.55%) | 10 Day Moving Average | $8.09(-12.05%) | 20 Day Moving Average | $8.53(-16.59%) | To recent high | -23.3% | To recent low | 0% | Market Cap | $442m | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |